Publications by authors named "P Wolkenstein"

Claim this Profile
C
Clinical benefits of selumetinib in adults with neurofibromatosis type 1 - Authors' reply.
Alice P Chen, Geraldine O'Sullivan Coyne, Pamela L Wolters, Pierre Wolkenstein

Lancet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hair follicle stem cell fate supports distinct clinical endotypes in hidradenitis suppurativa.
Audrey Onfroy, Francette Jean-Louis, Philippe Le Corvoisier, Fanny Coulpier, Kévin Muret, Pierre Wolkenstein

J Eur Acad Dermatol Venereol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse model.
Katarzyna J Radomska, Audrey Onfroy, Laure Lecerf, Bastien Job, Aurélien Beaude, Pierre Wolkenstein

Sci Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of immunogenicity during infliximab therapy in hidradenitis suppurativa compared with other chronic inflammatory diseases: A retrospective monocentric cohort.
Camille Barral, Ramatoulaye Ndiaye, Christina Bergqvist, Sophie Hue, Pierre Wolkenstein

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: Development, validation and severity strata of the cNF-PUSH-D.
Laura Fertitta, Kavita Y Sarin, Carlos G Romo, Christina Bergqvist, Jaishri O Blakeley, Pierre Wolkenstein

Br J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis